Literature DB >> 22864624

The implications of viral reservoirs on the elite control of HIV-1 infection.

Robert W Buckheit1, Maria Salgado, Karen O Martins, Joel N Blankson.   

Abstract

The mechanisms by which a small percentage of HIV-1 infected individuals known as elite suppressors or controllers are able to control viral replication are not fully understood. Early cases of viremic control were attributed to infection with defective virus, but subsequent work has demonstrated that infection with a defective virus is not the exclusive cause of control. Replication-competent virus has been isolated from patients who control viral replication, and studies have demonstrated that evolution occurs in plasma virus but not in virus isolates from the latent reservoir. Additionally, transmission pair studies have demonstrated that patients infected with similar viruses can have dramatically different outcomes of infection. An increased understanding of the viral factors associated with control is important to understand the interplay between viral replication and host control, and has implications for the design of an effective therapeutic vaccine that can lead to a functional cure of HIV-1 infection.

Entities:  

Mesh:

Year:  2012        PMID: 22864624     DOI: 10.1007/s00018-012-1101-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  76 in total

1.  Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.

Authors:  Karen A O'Connell; Timothy P Brennan; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

2.  Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.

Authors:  Florencia Pereyra; Sarah Palmer; Toshiyuki Miura; Brian L Block; Ann Wiegand; Alissa C Rothchild; Brett Baker; Rachel Rosenberg; Emily Cutrell; Michael S Seaman; John M Coffin; Bruce D Walker
Journal:  J Infect Dis       Date:  2009-09-15       Impact factor: 5.226

3.  Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors.

Authors:  Adam M Spivak; Maria Salgado; S Alireza Rabi; Karen A O'Connell; Joel N Blankson
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

4.  HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

Authors:  Olivier Lambotte; Faroudy Boufassa; Yoann Madec; Ahn Nguyen; Cécile Goujard; Laurence Meyer; Christine Rouzioux; Alain Venet; Jean-François Delfraissy
Journal:  Clin Infect Dis       Date:  2005-08-30       Impact factor: 9.079

5.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

6.  Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding.

Authors:  Adjoa Smalls-Mantey; Nicole Doria-Rose; Rachel Klein; Andy Patamawenu; Stephen A Migueles; Sung-Youl Ko; Claire W Hallahan; Hing Wong; Bai Liu; Lijing You; Johannes Scheid; John C Kappes; Christina Ochsenbauer; Gary J Nabel; John R Mascola; Mark Connors
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

7.  Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?

Authors:  Cécile Goujard; Marie-Laure Chaix; Olivier Lambotte; Christiane Deveau; Martine Sinet; Julien Guergnon; Valérie Courgnaud; Christine Rouzioux; Jean-François Delfraissy; Alain Venet; Laurence Meyer
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

8.  HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.

Authors:  Toshiyuki Miura; Mark A Brockman; Arne Schneidewind; Michael Lobritz; Florencia Pereyra; Almas Rathod; Brian L Block; Zabrina L Brumme; Chanson J Brumme; Brett Baker; Alissa C Rothchild; Bin Li; Alicja Trocha; Emily Cutrell; Nicole Frahm; Christian Brander; Ildiko Toth; Eric J Arts; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

9.  Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors.

Authors:  Maria Salgado; Timothy P Brennan; Karen A O'Connell; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  Retrovirology       Date:  2010-11-08       Impact factor: 4.602

10.  Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics.

Authors:  Kara G Lassen; Michael A Lobritz; Justin R Bailey; Samantha Johnston; Sandra Nguyen; Benhur Lee; Tom Chou; Robert F Siliciano; Martin Markowitz; Eric J Arts
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

View more
  11 in total

Review 1.  The Alphabet Soup of HIV Reservoir Markers.

Authors:  Radwa R Sharaf; Jonathan Z Li
Journal:  Curr HIV/AIDS Rep       Date:  2017-04       Impact factor: 5.071

2.  HIV antibody characterization as a method to quantify reservoir size during curative interventions.

Authors:  Peter D Burbelo; Ahmad Bayat; Craig S Rhodes; Rebecca Hoh; Jeffrey N Martin; Rémi Fromentin; Nicolas Chomont; Gero Hütter; Joseph A Kovacs; Steven G Deeks
Journal:  J Infect Dis       Date:  2013-11-28       Impact factor: 5.226

3.  SAMHD1 expression in blood cells of HIV-1 elite suppressors and viraemic progressors.

Authors:  Erin L Buchanan; Melissa A McAlexander; Kenneth W Witwer
Journal:  J Antimicrob Chemother       Date:  2014-10-23       Impact factor: 5.790

Review 4.  The microbiome and HIV persistence: implications for viral remission and cure.

Authors:  Wei Li A Koay; Lilly V Siems; Deborah Persaud
Journal:  Curr Opin HIV AIDS       Date:  2018-01       Impact factor: 4.283

5.  Long-term control of viral replication in a Group O, human immunodeficiency virus type 1-infected individual.

Authors:  Robert W Buckheit; Stephen B Sexauer; Ahmad R Sedaghat; Claus O Wilke; Oliver Laeyendecker; Christie R Basseth; Joel N Blankson
Journal:  AIDS Res Hum Retroviruses       Date:  2014-06       Impact factor: 2.205

6.  Opening Fronts in HIV Vaccine Development: Targeting reservoirs to clear and cure.

Authors:  Robert F Siliciano
Journal:  Nat Med       Date:  2014-05       Impact factor: 53.440

7.  Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection.

Authors:  Matt A Price; Wasima Rida; William Kilembe; Etienne Karita; Mubiana Inambao; Eugene Ruzagira; Anatoli Kamali; Eduard J Sanders; Omu Anzala; Eric Hunter; Susan Allen; Vinodh A Edward; Kristin M Wall; Jianming Tang; Patricia E Fast; Pontiano Kaleebu; Shabir Lakhi; Gaudensia Mutua; Linda Gail Bekker; Ggayi Abu-Baker; Amanda Tichacek; Paramesh Chetty; Mary H Latka; Pholo Maenetje; Heeran Makkan; Freddie Kibengo; Fran Priddy; Jill Gilmour
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

Review 8.  The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence.

Authors:  Alexandra J Murray; Kyungyoon J Kwon; Donna L Farber; Robert F Siliciano
Journal:  J Immunol       Date:  2016-07-15       Impact factor: 5.422

9.  The global transmission network of HIV-1.

Authors:  Joel O Wertheim; Andrew J Leigh Brown; N Lance Hepler; Sanjay R Mehta; Douglas D Richman; Davey M Smith; Sergei L Kosakovsky Pond
Journal:  J Infect Dis       Date:  2013-10-22       Impact factor: 5.226

10.  Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities.

Authors:  Jason W Rausch; Stuart F J Le Grice
Journal:  Curr HIV Res       Date:  2020       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.